POLR3A-related spastic ataxia: new mutations and a look into the phenotype.
Jon InfanteKarla M Serrano-CárdenasMarc Corral-JuanXavier FarréIvelisse SánchezEnrique M de LucasAntonio GarcíaJosé Luis Martín-GurpeguiJosé BercianoAntoni Matilla-DueñasPublished in: Journal of neurology (2019)
Adolescent-onset spastic ataxia is a proposed novel phenotype in compound heterozygous carriers of an intronic mutation (c.1909 + 22G > A) in the POLR3A gene. Here, we present ten new cases of POLR3A-related spastic ataxia and discuss the genetic, clinical and imaging findings. Patients belonged to six pedigrees with hereditary spastic paraplegia or cerebellar ataxia of unknown origin. All affected subjects presented with compound heterozygous variants, comprising c.1909 + 22G > A in combination in each pedigree with one of the following novel mutations (Thr596Met, Tyr665LeufsTer11, Glu198Ter, c.646-687_1185 + 844del). The new mutations segregated with the phenotype in all families. The phenotype combined variable cerebellar ataxia, gait and lower limb spasticity, involvement of central sensory tracts and in some cases also intention tremor. The reportedly characteristic hyperintensity along the superior cerebellar peduncle on MRI was observed in ~ 80% of the cases. Our study extends the clinical and molecular phenotype further supporting the pathogenic role of the c.1909 + 22G4A intronic mutation and identifying four novel causative mutations in POLR3A-related spastic ataxia. Certain characteristic MRI features may be useful to guide genetic diagnosis.
Keyphrases
- cerebral palsy
- early onset
- botulinum toxin
- upper limb
- lower limb
- copy number
- genome wide
- magnetic resonance imaging
- end stage renal disease
- contrast enhanced
- young adults
- ejection fraction
- prognostic factors
- mental health
- diffusion weighted imaging
- parkinson disease
- mass spectrometry
- computed tomography
- magnetic resonance